Influence of level of dietary protein or energy on effects of ractopamine in finishing swine.
The effect of ractopamine, a beta-adrenergic agonist, on growth, nutrient utilization, and carcass composition was studied in pigs fed either 18% CP, 12% CP, or 18% CP restricted (RES = 67% of ad libitum) diets. The 18 and 12% CP diets provided 3.52 and 3.68 Mcal of DE/kg, respectively. All pigs were fed a low-protein (12% CP) diet during pretreatment growth from 15 to 60 kg. Ractopamine at 20 or 30 ppm (30 ppm for RES pigs) in the diet was fed from 60 kg live BW until slaughter at 105 kg (9 pigs/treatment). No ractopamine treatment effect (P greater than .05) was observed for either daily gain or gain/feed, although gain/feed was improved by 8% in both of the ad libitum groups. Ractopamine treatment resulted (P less than .01) in an overall reduction of carcass lipid by 8%, an increase of carcass protein by 5%, and a 21% improvement in the efficiency of protein utilization; the greatest changes occurred in the pigs fed the 12% CP diet (-17%, +11%, and +32%, respectively). The ad libitum daily feed intake was 15% less for pigs fed the 12% CP diet than for those fed the 18% CP diet (P less than .01), and there was a 10% reduction in intake of both diets with the addition of ractopamine (P less than .05). Both carcass lipid and protein deposition seemed to be closely related to energy intake (P less than .01).(ABSTRACT TRUNCATED AT 250 WORDS)
Mitchell
A D
AD
USDA, ARS, Beltsville Agric. Res. Center, MD 20705.
Solomon
M B
MB
Steele
N C
NC
D000273:Adipose Tissue / Q000033:anatomy & histology / Q000187:drug effects; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D001823:Body Composition / Q000187:drug effects; D004044:Dietary Proteins / Q000008:administration & dosage*; D004435:Eating / Q000187:drug effects; D002149:Energy Intake; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010627:Phenethylamines / Q000494:pharmacology*; D013552:Swine / Q000033:anatomy & histology / Q000254:growth & development*; D015430:Weight Gain / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D004044:Dietary Proteins; D010627:Phenethylamines; C060897:ractopamine